The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
April 18th 2025
Recently published research projected that 103,000 future cases of radiation-induced cancer would result from 93 million computed tomography (CT) exams performed in the United States in 2023.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
In vitro diagnostics: natural next choice for M&A
January 31st 2001The obvious targets for merger and acquisition are gone. The flurry of purchases undertaken in 2000 pretty much cleared the deck of single-modality vendors. SMV is part of GE; ADAC Laboratories has become the nuclear medicine division of Philips; Agilent
Nuclear medicine regs face fresh opposition
January 17th 2001Rankled by proposed revisions to the long-standing regulations that govern diagnostic nuclear medicine, two trade organizations have filed a joint petition asking the Nuclear Regulatory Commission to revoke a portion of a pending rule that would impose
Philips puts up $426 million to acquire nuclear leader ADAC Laboratories
November 22nd 2000By Robert BruceRoyal Philips Electronics announced last week that it has agreed to acquire ADAC Laboratories for $426 million, or $18.50 a share of ADAC's outstanding common stock. The offer is subject to regulatory approval. It is good until Dec. 12 and
Siemens claims top market share among nuclear medicine companies
November 8th 2000Company shows big growth in PET and gamma cameras Based in large part on substantial sales growth for its PET and gamma camera products, Siemens Medical Systems has laid claim to the top market share spot worldwide in nuclear medicine.Siemens
SMV receives first FDA clearance for PET/CT hybrid system
September 13th 2000SMV’s Positrace, the first commercially available PET/CT system, obtained FDA 510(k) clearance Sept. 1, just days before the European Association of Nuclear Medicine meeting began in Paris.Although GE Medical Systems has a 510(k) clearance for its
GE to acquire Elscint’s share in ELGEMS
September 13th 2000GE Medical Systems and Elscint have reached an agreement in which GE will acquire Elscint’s 50% share of ELGEMS, a joint venture formed in 1997 by the two companies to manufacture nuclear imaging systems, for $30 million.As a result of the
Marconi unveils single-head gamma camera
August 16th 2000Marconi Medical Systems has a new offering in its line of nuclear medicine products. The single-head system, called Meridian, complements the existing line of dual- and triple-head cameras that have become the company’s standard bearers.Meridian
Marconi testing MR and NM oncology tools
August 2nd 2000Marconi Medical Systems is expanding its oncology business beyond CT to MR and nuclear medicine with new screening tools and is signing business agreements with several companies and international health centers.Marconi formally launched its
SMV expects clearance for PET/CT this summer
July 5th 2000At this year’s Society of Nuclear Medicine meeting, imaging systems that fused PET with CT was a feature seen at a few vendor booths, including GE and SMV of Ohio. SMV displayed a combination PET/CT system called Positrace that was first seen at
Syncor inks three deals to expand nuclear medicine base
June 21st 2000Will increase FDG output and sales forcePharmaceutical manufacturer Syncor of Woodland Hills, CA, struck three deals this month that will expand its presence and customer base in the nuclear medicine industry. The company aims to build the
ADAC to ship Skylight sometime after October
June 7th 2000ADAC Laboratories has a first customer for its recently approved Skylight nuclear medicine camera: Cedars-Sinai Medical Center in Los Angeles.Cedars-Sinai placed an order for the $1 million imaging device, along with a C-PET positron emission
SNM announces deal with GE for Web-based CME project
May 10th 2000The Society of Nuclear Medicine announced its first exclusive alliance with a single industry vendor when it joined with General Electric Medical Systems to develop educational programs for the nuclear medicine community.According to the agreement, the
Syncor acquires Trinidad and Tobago MRI center
April 26th 2000Syncor Overseas, a subsidiary of nuclear pharmaceutical and medical imaging company Syncor, has acquired MRI Trinidad and Tobago, an MRI center in Port of Spain, Trinidad and Tobago. Syncor acquired the center from Magnetic Resonance Imaging of Trinidad
ADAC announces new CT simulation package
April 26th 2000ADAC Laboratories, a manufacturer of nuclear medicine and radiation therapy planning systems, believes it is tapping into a new market for CT simulation products with the introduction of its SmartSim package. SmartSim is an integrated CT simulation and
CT and MRI studies expected to hit $45 million this year
March 29th 2000Nuclear cardiac perfusion studies are growing “by leaps and bounds,” according to an industry analyst, while cardiac MR and cardiac CT hover around 1% of total studies in those modalities.In 1993, cardiac perfusion studies made up only 38% of
Dedicated PET, fusion technology stimulate nuclear medicine interest
January 12th 2000Nuclear medicine firms arrived at the RSNA meeting optimistic about the modality’s potential for growth. Despite an overall flat market in 1999, vendors predict sales will climb over the next two years from $700 million to more than $1 billion,
ADAC debuts gantryless dual-head gamma camera at RSNA meeting
December 15th 1999Vendor believes Skylight could expand nuclear applications Following up on the 1998 RSNA introduction of its dual-head, open-gantry-design Forte gamma camera, ADAC Laboratories took the open gantry concept to its logical conclusion with the 1999
ADAC sees sharp 1999 net income decline
November 24th 1999Nuclear medicine vendor ADAC Laboratories reported mixed results this month when it posted its fiscal 1999 and fourth quarter (end-October) results. After more than a year of financial problems that included restating its revenues for the past three
ATL launches real-time perfusion echocardiography software
November 24th 1999Technology makes use of ultrasound contrast agents Ultrasound developers have long sought to broaden the reach of the modality to support myocardial perfusion imaging. But sonography has not yet been able to compete with nuclear medicine and
CTI, Mobile PET launch European PET unit
November 10th 1999CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals.
GE gets OK for functional anatomical mapping
October 13th 1999Only months after introducing its Functional Anatomic Mapping technology at the Society of Nuclear Medicine meeting (SCAN 6/23/99), GE Medical Systems has won clearance for the technique from the Food and Drug Administration. The technology
Schering plans purchase of peptide developer Diatide
September 29th 1999Deal continues Schering’s push into nuclear medicineThe radiopharmaceutical industry underwent some consolidation this month with the announcement that Schering AG’s management holding company, Schering Berlin, and its acquisition arm,
DOE seeks private partnerfor medical radioisotopes production
August 4th 1999Los Alamos, Sandia funding remains uncertainThe U.S. Department of Energy clarified its plans for providing medical isotopes to the U.S. nuclear medicine community at June’s Society of Nuclear Medicine meeting in Los Angeles. At the meeting,
ADAC struggles to regain footing as financial woes discourage investors
August 4th 1999Prospects strongest in PET, therapy planning, and HISNuclear medicine vendor ADAC Laboratories is enduring a tough period of business right now, particularly in its relationship with investors and the financial markets. The company no longer
Nuclear medicine market sees solid growth as PET shows signs of commercial viability
July 7th 1999Hybrid systems, expanded reimbursement take center stage at SNM meetingFor vendors at this year’s Society of Nuclear Medicine show in Los Angeles, the industry’s hard times of the mid-1990s were only a memory. While the meeting suffered